Showing results (871-880 of 991) with videos related to

Sort By:
Pageof 100
Molecular Cancer Therapeutics|August 24, 2023
SGN-B6A: A New Vedotin Antibody-Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma IndicationsRobert P Lyon, Mechthild Jonas, Christopher Frantz, et al.
Frontiers in Immunology|July 8, 2026
Comparative assessment of tissue cross-reactivity and pharmacokinetic half-life of malaria monoclonal antibodiesWilliam R Fugina, Dallas R Brown, Shelby Foor, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Pace of Aging in older adults matters for healthspan and lifespanA Balachandran, H Pei, Y Shi, et al.
Reproductive Toxicology (Elmsford, N.Y.)|September 17, 2017
Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspringSimone M Nicholson, Gianluca Carlesso, Lily I Cheng, et al.
British Journal of Cancer|June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancersL M Smith, A Nesterova, M C Ryan, et al.
Sexually Transmitted Infections|October 15, 2014
Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New GuineaR A Wangnapi, S Soso, H W Unger, et al.
Neuron|November 16, 2001
A visual pigment expressed in both rod and cone photoreceptorsJ Ma, S Znoiko, K L Othersen, et al.
Nature Biotechnology|May 29, 2019
A coiled-coil masking domain for selective activation of therapeutic antibodiesVivian H Trang, Xinqun Zhang, Roma C Yumul, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasisJena J Steinle, Qiuhua Zhang, Karin Emmons Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaQin C Ryan, Donna Headlee, Milin Acharya, et al.
Pageof 100